BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding Z, Zhou M, Zeng C. Recent advances in isatin hybrids as potential anticancer agents. Arch Pharm (Weinheim) 2020;353:e1900367. [PMID: 31960987 DOI: 10.1002/ardp.201900367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheke RS, Patil VM, Firke SD, Ambhore JP, Ansari IA, Patel HM, Shinde SD, Pasupuleti VR, Hassan MI, Adnan M, Kadri A, Snoussi M. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery. Pharmaceuticals 2022;15:272. [DOI: 10.3390/ph15030272] [Reference Citation Analysis]
2 Wang Y, Ding R, Tai Z, Hou H, Gao F, Sun X. Artemisinin-isatin hybrids with potential antiproliferative activity against breast cancer. Arabian Journal of Chemistry 2022;15:103639. [DOI: 10.1016/j.arabjc.2021.103639] [Reference Citation Analysis]
3 Wan Y, Long J, Gao H, Tang Z. 2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents. Eur J Med Chem 2021;210:112953. [PMID: 33148490 DOI: 10.1016/j.ejmech.2020.112953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Marchese AD, Larin EM, Mirabi B, Lautens M. Metal-Catalyzed Approaches toward the Oxindole Core. Acc Chem Res 2020;53:1605-19. [PMID: 32706589 DOI: 10.1021/acs.accounts.0c00297] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
5 Eldehna WM, El Hassab MA, Abo-Ashour MF, Al-Warhi T, Elaasser MM, Safwat NA, Suliman H, Ahmed MF, Al-Rashood ST, Abdel-Aziz HA, El-Haggar R. Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations. Bioorg Chem 2021;110:104748. [PMID: 33684714 DOI: 10.1016/j.bioorg.2021.104748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Eldeeb M, Sanad EF, Ragab A, Ammar YA, Mahmoud K, Ali MM, Hamdy NM. Anticancer Effects with Molecular Docking Confirmation of Newly Synthesized Isatin Sulfonamide Molecular Hybrid Derivatives against Hepatic Cancer Cell Lines. Biomedicines 2022;10:722. [DOI: 10.3390/biomedicines10030722] [Reference Citation Analysis]
7 Ali EMH, Mersal KI, Ammar UM, Zaraei SO, Abdel-Maksoud MS, El-Gamal MI, Haque MM, Das T, Kim EE, Lee JS, Lee KH, Kim HK, Oh CH. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study. Eur J Pharm Sci 2022;171:106115. [PMID: 34995782 DOI: 10.1016/j.ejps.2022.106115] [Reference Citation Analysis]
8 Zhang Z, Zhang D, Zhou Y, Wang F, Xin A, Gao F, Wang P, Zhang P. The anti-lung cancer activity of propylene tethered dihydroartemisinin-isatin hybrids. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.103721] [Reference Citation Analysis]
9 Eldehna WM, Abo-Ashour MF, Al-Warhi T, Al-Rashood ST, Alharbi A, Ayyad RR, Al-Khayal K, Abdulla M, Abdel-Aziz HA, Ahmad R, El-Haggar R. Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells. J Enzyme Inhib Med Chem 2021;36:319-28. [PMID: 33345633 DOI: 10.1080/14756366.2020.1862100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tawfik NG, Mohamed WR, Mahmoud HS, Alqarni MA, Naguib IA, Fahmy AM, Ahmed OM. Isatin Counteracts Diethylnitrosamine/2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male Wistar Rats by Upregulating Anti-Inflammatory, Antioxidant, and Detoxification Pathways. Antioxidants 2022;11:699. [DOI: 10.3390/antiox11040699] [Reference Citation Analysis]
11 Sarhan MO, Abd El-Karim SS, Anwar MM, Gouda RH, Zaghary WA, Khedr MA. Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D QSAR, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution Studies. Molecules 2021;26:2273. [PMID: 33919867 DOI: 10.3390/molecules26082273] [Reference Citation Analysis]
12 Eldehna WM, Salem R, Elsayed ZM, Al-Warhi T, Knany HR, Ayyad RR, Traiki TB, Abdulla MH, Ahmad R, Abdel-Aziz HA, El-Haggar R. Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer. J Enzyme Inhib Med Chem 2021;36:1424-35. [PMID: 34176414 DOI: 10.1080/14756366.2021.1944127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Al-Warhi T, El Kerdawy AM, Aljaeed N, Ismael OE, Ayyad RR, Eldehna WM, Abdel-Aziz HA, Al-Ansary GH. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors. Molecules 2020;25:E2031. [PMID: 32349307 DOI: 10.3390/molecules25092031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
14 Ferraz de Paiva RE, Vieira EG, Rodrigues da Silva D, Wegermann CA, Costa Ferreira AM. Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency. Front Mol Biosci 2020;7:627272. [PMID: 33614708 DOI: 10.3389/fmolb.2020.627272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Solangi M, Kanwal, Khan KM, Chigurupati S, Saleem F, Qureshi U, Ul-Haq Z, Jabeen A, Felemban SG, Zafar F, Perveen S, Taha M, Bhatia S. Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies. Arch Pharm (Weinheim) 2022;:e2100481. [PMID: 35355329 DOI: 10.1002/ardp.202100481] [Reference Citation Analysis]
16 Yousef MA, Ali AM, El-Sayed WM, Qayed WS, Farag HHA, Aboul-Fadl T. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents. Bioorg Chem 2020;105:104366. [PMID: 33212312 DOI: 10.1016/j.bioorg.2020.104366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Marek L, Váňa J, Svoboda J, Hanusek J. Synthesis of the Kinase Inhibitors Nintedanib, Hesperadin, and Their Analogues Using the Eschenmoser Coupling Reaction. J Org Chem 2021;86:10621-9. [PMID: 34269051 DOI: 10.1021/acs.joc.1c01269] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mokhtar M, Alghamdi KS, Ahmed NS, Bakhotmah D, Saleh TS. Design and green synthesis of novel quinolinone derivatives of potential anti-breast cancer activity against MCF-7 cell line targeting multi-receptor tyrosine kinases. J Enzyme Inhib Med Chem 2021;36:1454-71. [PMID: 34210212 DOI: 10.1080/14756366.2021.1944126] [Reference Citation Analysis]
19 Guo H, Diao QP. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds. Curr Top Med Chem 2020;20:1499-503. [PMID: 32156238 DOI: 10.2174/1568026620666200310124416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]